Katama Biomed Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.32 M
- Company Age 38 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.19 Cr
- Revenue Growth 101.52%
- Profit Growth -62.99%
- Ebitda -69.89%
- Net Worth 44.12%
- Total Assets 37.01%
About Katama Biomed
Katama Biomed Private Limited (KBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 March 1986 and has a history of 38 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Corporate was formerly known as Frank Surgicare Private Limited. The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.32 M.
The company currently has active open charges totaling ₹2.19 Cr.
Senthilram and Lavanya serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24246TN1986PTC012760
-
Company No.
012760
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Mar 1986
-
Date of AGM
15 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Katama Biomed?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilram
|
Director | 04-Jul-2016 | Current |
|
Lavanya
|
Director | 18-Mar-2019 | Current |
Financial Performance of Katama Biomed.
Katama Biomed Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 101.52% increase. The company also saw a substantial fall in profitability, with a 62.99% decrease in profit. The company's net worth Soared by an impressive increase of 44.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Katama Biomed?
Unlock access to Katama Biomed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
D Mterraa Private LimitedSenthilram is a mutual person
Charges (Loans)
₹21.90 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 1.25 Cr
- Corporation Bank : 0.60 Cr
- Technology Developement & Information Company Of India Ltd. : 0.34 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2024 | Yes Bank Limited | ₹1.25 Cr | Open |
| 14 Nov 2003 | Corporation Bank | ₹2.00 M | Open |
| 14 Nov 2003 | Corporation Bank | ₹2.00 M | Open |
| 13 Nov 2003 | Corporation Bank | ₹2.00 M | Open |
| 25 Sep 1989 | Technology Developement & Information Company Of India Ltd. | ₹3.40 M | Open |
How Many Employees Work at Katama Biomed?
Unlock and access historical data on people associated with Katama Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Katama Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Katama Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
